918 results match your criteria gynecologic oncologists


The Contribution of the European School Of Oncology Education to the Central Asian and Caucasian Regions.

J Cancer Educ 2021 Jul 22. Epub 2021 Jul 22.

European School of Oncology, Milan, Italy.

The European School of Oncology (ESO) organizes educational activities within Europe, the Mediterranean region, Central Asia, and the Caucasus. In this paper, we report on the participation of oncologists from Uzbekistan, Kazakhstan, Kirgizstan, Tajikistan, Azerbaijan, Georgia, and Armenia in various ESO activities including the masterclass, courses, refresher courses, conventions, conferences, consensus conferences, clinical training centers fellowship program, and the medical students' courses in oncology. Over the last 15 years, 428 oncologists and medical students have successfully attended one or more of the above activities organized in various European countries. Read More

View Article and Full-Text PDF

Gaps in patient-physician communication at the time of malignant bowel obstruction from recurrent gynecologic cancer: a qualitative study.

Support Care Cancer 2021 Jul 21. Epub 2021 Jul 21.

Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Chicago Medical Center, Chicago, IL, USA.

Purpose: We sought to investigate the patient and physician approaches to malignant bowel obstruction (MBO) due to recurrent gynecologic cancer by (1) comparing patient and physician expectations and priorities during a new MBO diagnosis, and (2) highlighting factors that facilitate patient-doctor communication.

Methods: Patients were interviewed about their experience during an admission for MBO, and physicians were interviewed about their general approach towards MBO. Interviews were analyzed for themes using QDAMiner qualitative analysis software. Read More

View Article and Full-Text PDF

MAID ready for primetime?: A survey of SGO members regarding medical aid in dying (MAID).

Gynecol Oncol Rep 2021 Aug 5;37:100829. Epub 2021 Jul 5.

University of Colorado Health, Department of OB/GYN, Division of Gynecologic Oncology, Denver, CO, USA.

Objectives: To assess SGO members' knowledge, attitudes, and practice patterns regarding Medical Aid In Dying (MAID).

Methods: SGO members were surveyed via online survey. The survey included questions regarding demographics, knowledge, attitudes, and practice patterns relating to MAID. Read More

View Article and Full-Text PDF

Pyogenic Spondylitis in Multidisciplinary Therapies of Gynecologic Malignancies: Three Cases Reports.

Tokai J Exp Clin Med 2021 Jul 20;46(2):118-122. Epub 2021 Jul 20.

Department Obstetrics and Gynecology, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan.

Both during and after cancer treatment, pyogenic spondylitis is an uncommon but serious complication. Because pyogenic spondylitis is often recognized as a complication of a distant process causing bacteremia, it initially may be misdiagnosed the primary infection such as urinary tract infection. Consequently, a considerable delay in diagnosis frequently occurs. Read More

View Article and Full-Text PDF

Segmentation of acetowhite region in uterine cervical image based on deep learning.

Technol Health Care 2021 Jun 25. Epub 2021 Jun 25.

Department of Information Engineering, Nanchang Hangkong University, Nanchang, Jiangxi 330036, China.

Background: Acetowhite (AW) region is a critical physiological phenomenon of precancerous lesions of cervical cancer. An accurate segmentation of the AW region can provide a useful diagnostic tool for gynecologic oncologists in screening cervical cancers. Traditional approaches for the segmentation of AW regions relied heavily on manual or semi-automatic methods. Read More

View Article and Full-Text PDF

Patterns and Trends of Herbal Medicine Use among Patients with Gynecologic Cancer.

Geburtshilfe Frauenheilkd 2021 Jun 21;81(6):699-707. Epub 2021 Jun 21.

Department of Gynecology and Obstetrics, Alb Fils Kliniken, Klinik am Eichert, Göppingen, Germany.

More and more information about complementary and integrative medicine is becoming available, especially among cancer patients. However, little is known about the use of herbal medicine by patients with gynecologic cancers. This study aimed to assess the use of herbal products by gynecologic cancer patients compared with healthy controls. Read More

View Article and Full-Text PDF

An Italian National Survey on Ovarian Cancer Treatment at first diagnosis. There's None so Deaf as those who will not Hear.

J Cancer 2021 27;12(15):4443-4454. Epub 2021 May 27.

Unit of Surgical Gynecol Oncology, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Epithelial ovarian cancer (EOC) is the most lethal gynecological malignancy, crucial prognostic factors are no gross residual disease and centralization of cases. To evaluate the centralization of EOC patients, we report the results of a survey that shows the daily management of EOC patients in Italy. A 49-items electronic unblinded survey assessing demographics, practice characteristics, current opinions and approach to managing advanced EOC at first diagnosis was sent both to general gynecologists (GG) and gynecologic oncologists (GO). Read More

View Article and Full-Text PDF

Potential Strategies to Increase Gynecologic Oncologist Treatment for Ovarian Cancer.

J Womens Health (Larchmt) 2021 Jun;30(6):769-781

ICF, Atlanta, Georgia, USA.

Evidence shows that treatment by gynecologic oncologists (GOs) increases overall survival among women with ovarian cancer. However, specific strategies for institutions and community-based public health programs to promote treatment by GOs are lacking. To address this, we conducted a literature review to identify evidence-based and promising system- and environmental-change strategies for increasing treatment by GOs, in effort to ensure that all women with ovarian cancer receive the standard of care. Read More

View Article and Full-Text PDF

Trends and geographic variation in women's representation as principal investigators (PI) in phase 3 gynecologic oncology clinical trials.

Gynecol Oncol 2021 Jun 4. Epub 2021 Jun 4.

Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego, Moores Cancer Center, La Jolla, CA, United States of America.

Objective: To investigate the representation of women as principal investigators (PI) in phase 3, gynecologic oncology clinical trials.

Methods: ClinicalTrials.gov was queried for all phase 3 clinical trials with start dates between January 1, 2010 and December 31, 2020 using the search terms: "ovarian cancer", "endometrial cancer", and "cervical cancer". Read More

View Article and Full-Text PDF

Educational contribution of the College of the European School of Oncology to the Latin American Oncologists.

Future Oncol 2021 Jun 8. Epub 2021 Jun 8.

European School of Oncology, Via Turati 29, 20121, Milan, Italy.

The European School of Oncology (ESO) offers a wide range of educational activities in Europe, the Middle East and Latin America. International experts are invited to provide proper education in the diagnosis and treatment of patients with cancer according to a holistic model of care. This activity is currently structured in the ESO College (ESCO) through masterclasses in clinical oncology, international conferences, clinical training centers fellowship programs, certificate of competence and advanced studies, patients' advocacy events, e-learning sessions and medical students' courses in oncology. Read More

View Article and Full-Text PDF

Terms, definitions and measurements to describe sonographic features of lymph nodes: consensus opinion from the Vulvar International Tumor Analysis (VITA) group.

Ultrasound Obstet Gynecol 2021 Jun;57(6):861-879

Department of Obstetrics and Gynecology, Skåne University Hospital, Malmö, Sweden.

In centers with access to high-end ultrasound machines and expert sonologists, ultrasound is used to detect metastases in regional lymph nodes from melanoma, breast cancer and vulvar cancer. There is, as yet, no international consensus on ultrasound assessment of lymph nodes in any disease or medical condition. The lack of standardized ultrasound nomenclature to describe lymph nodes makes it difficult to compare results from different ultrasound studies and to find reliable ultrasound features for distinguishing non-infiltrated lymph nodes from lymph nodes infiltrated by cancer or lymphoma cells. Read More

View Article and Full-Text PDF

Implementation of an enhanced recovery protocol in gynecologic oncology.

Gynecol Oncol Rep 2021 May 30;36:100771. Epub 2021 Apr 30.

Hanjani Institute for Gynecologic Oncology, Asplundh Cancer Pavilion, Abington Hospital-Jefferson Health, 3941 Commerce Avenue, Willow Grove, PA 19090, United States.

Enhanced Recovery after Surgery (ERAS) is an evidence-based approach that aims to reduce narcotic use and maintain anabolic balance to enable full functional recovery. Our primary aim was to determine the effect of ERAS on narcotic usage among patients who underwent exploratory laparotomy by gynecologic oncologists. We characterized its effect on length of stay, intraoperative blood transfusions, bowel function, 30-day readmissions, and postoperative complications. Read More

View Article and Full-Text PDF

Leptomeningeal metastasis from cervical cancer: Report of two cases and a review of the literature.

J Obstet Gynaecol Res 2021 May 17. Epub 2021 May 17.

Department of Obstetrics and Gynecology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.

Leptomeningeal metastases from cervical cancer are extremely rare, with only 24 cases reported in the English-language literature. Leptomeningeal metastasis (LM) is usually a late event, but it can develop at any stage. A 44-year-old woman presented with vertigo, tinnitus, diminution of hearing, and a cervical tumor at the initial visit. Read More

View Article and Full-Text PDF

Management and Recommendations for Future Pregnancy in Patients with Early-Stage Endometrial Cancer: A Survey of Gynecologic Oncologists and Reproductive Endocrinology and Infertility Specialists.

J Adolesc Young Adult Oncol 2021 May 6. Epub 2021 May 6.

Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

To determine how young patients with early-stage endometrial cancer are counseled regarding fertility preserving therapy and pregnancy options by gynecologic oncology and reproductive endocrinology and infertility (REI) providers. Anonymous online survey of Society of Gynecology Oncology (SGO) and the Society for Reproductive Endocrinology and Infertility (SREI) members; data were analyzed using chi-square and -tests. Twelve percent (169/1433) of SGO and 6. Read More

View Article and Full-Text PDF

Differences in Family Planning and Fertility Among Female and Male Gynecologic Oncologists.

Womens Health Rep (New Rochelle) 2021 8;2(1):78-84. Epub 2021 Apr 8.

Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, Minnesota, USA.

The objective of the study was to compare family planning and infertility among female and male gynecologic oncologists in the United States This cross-sectional multiple choice survey was administered to the Society of Gynecologic Oncology gynecologic oncologists. The survey collected information on demographics and practice, family planning, and fertility and infertility experiences. Chi-square and Fisher's exact tests were used to compare experiences by gender. Read More

View Article and Full-Text PDF

The puzzle of gynecologic neuroendocrine carcinomas: State of the art and future directions.

Crit Rev Oncol Hematol 2021 Jun 29;162:103344. Epub 2021 Apr 29.

Department of Maternal and Child Health and Urological Sciences, University of Rome "Sapienza", Policlinico "Umberto I", Rome, Italy.

Primary gynecologic neuroendocrine carcinomas (gNECs) are a heterogeneous spectrum of rare and highly aggressive neoplasms, accounting for about 2% of all gynecologic malignancies, which mostly resemble the small cell lung carcinoma (SCLC). Due to the lack of standardized treatment guidelines, their management poses a noteworthy clinical challenge. Currently, cumulative data retrieved from the management of SCLC and from retrospective studies supports a multimodality strategy, based on surgery, chemotherapy, and radiotherapy. Read More

View Article and Full-Text PDF

Is a tailored strategy using proton beam radiotherapy for reirradiation advantageous for elderly women? A case report.

Tumori 2021 Apr 25:3008916211007930. Epub 2021 Apr 25.

Radiation Oncology, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.

Background: The management of primary or recurrent vaginal tumours in an aging population is challenging for gynecologic and radiation oncologists. In patients unsuited for surgery and already irradiated on the pelvis, proton beam radiotherapy may be worthwhile due to its ballistic advantages.

Case Report: We report the case of an 80-year-old woman with a squamous cell carcinoma of the vagina after a history of pelvic radiation and vaginal brachytherapy delivered for a previous endometrial adenocarcinoma. Read More

View Article and Full-Text PDF

The impact of expanding gynecologic oncology care to ovarian cancer patients in small cities and rural communities.

Gynecol Oncol 2021 Jun 20;161(3):852-857. Epub 2021 Apr 20.

Western Michigan University Homer Stryker M.D. School of Medicine, 300 Portage Street, Kalamazoo, MI 49007, United States; West Michigan Cancer Center, 200 N Park Street, Kalamazoo, MI 49007, United States. Electronic address:

Objective: Patients with ovarian cancer from smaller cities and rural communities face unique challenges in accessing comprehensive care. This study compares management strategies, outcomes, and access to care for patients in a small city and surrounding rural communities before and after establishing a full-time gynecologic oncology (GO) office.

Methods: A local tumor registry was used to identify patients diagnosed with ovarian cancer before and after a full-time GO office was established. Read More

View Article and Full-Text PDF

Diaphragm hernia after debulking surgery in patients with ovarian cancer.

Gynecol Oncol Rep 2021 May 31;36:100759. Epub 2021 Mar 31.

Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Over 80% of patients with epithelial ovarian cancer present with advanced disease, FIGO stage III or IV at the time of diagnosis. The majority require extensive upper abdominal surgery to obtain complete gross resection. This may include splenectomy, distal pancreatectomy, partial hepatectomy, cholecystectomy, and usually diaphragmatic peritonectomy or resection. Read More

View Article and Full-Text PDF

Suprarenal lymphadenectomy with nephrectomy for refractory ovarian cancer.

Gland Surg 2021 Mar;10(3):1268-1270

Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.

The effect of debulking surgery is not vague in patients with refractory ovarian cancer because of drug-resistant tumor biology showing rapid growth. However, it can be considered to be beneficial for selected patients expected to show tumor response by postoperative treatment because the better perfused small tumors may favor the action of cytotoxic therapy. Among them, patients with enlarged lymph nodes and mutations can show a relatively high rate of response and improved survival by systematic lymphadenectomy followed by poly ADP ribose polymerase (PARP) inhibitors. Read More

View Article and Full-Text PDF

Extrapelvic bowel resection and anastomosis in cytoreductive surgery for ovarian cancer.

Gland Surg 2021 Mar;10(3):1207-1211

Division of Gynecologic Oncology, Ajou University School of Medicine, Suwon, Korea.

Ovarian cancer is known as the second most common cause of death among gynecologic cancers. Survival outcome has been reported to be significantly associated with the efforts to minimize residual disease after cytoreductive surgery. As ovarian cancer often invades the small and large bowel without boundary, bowel surgery has been a crucial part of the cytoreductive surgery to achieve complete tumor removal. Read More

View Article and Full-Text PDF

First Case Report of Pregnancy on Alectinib in a Woman With Metastatic ALK-Rearranged Lung Cancer: A Case Report.

J Thorac Oncol 2021 05 30;16(5):873-877. Epub 2021 Mar 30.

Department of Oncology, Mario Negri Institute for Pharmacological Research IRCCS, Milan, Italy.

This is the first case report of a patient with ALK-rearranged metastatic lung adenocarcinoma who became pregnant during treatment with alectinib. A multidisciplinary team of gynecologists, neonatologists, oncologists, psychologists, and pharmacologists was set up to handle the case. According to patient's preference, the study drug was continued throughout pregnancy and the woman delivered a healthy baby girl at 35 weeks and 5 days of gestation. Read More

View Article and Full-Text PDF

Pelvic anatomy for gynecologic oncologists: autonomic bladder plexus.

Int J Gynecol Cancer 2021 Jun 29;31(6):936-937. Epub 2021 Mar 29.

Institute Clinic of Gynecology, Obstetrics and Neonatology, Hospital Clinic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.

View Article and Full-Text PDF

Guillain-Barre Syndrome in a patient with uterine adenocarcinoma undergoing treatment with immune-checkpoint inhibitor therapy: A case report and review of the literature.

Gynecol Oncol Rep 2021 May 2;36:100739. Epub 2021 Mar 2.

Division of Gynecologic Oncology, Medical College of Georgia at Augusta University, Augusta, GA, United States.

Background: Use of immune checkpoint inhibitors in treatment of gynecologic malignancies is increasing. Rare, but potentially fatal, immune-related neurologic adverse events may occur as a result of treatment.

Case: A 72 year old female with recurrent metastatic uterine adenocarcinoma received pembrolizumab and lenvatinib combination therapy. Read More

View Article and Full-Text PDF

Live European School of Oncology e-Sessions (e-ESO).

Crit Rev Oncol Hematol 2021 Jul 16;163:103301. Epub 2021 Mar 16.

European School of Oncology, Milan, Italy.

The European School of Oncology (ESO) embarked on an online educational project, starting with live sessions in 2008 (e-ESO). Our scholars and young oncologists identified the need to be offered independent high-level online education with contributions from experts around the world, free of charge and available at any moment. We report on various types of e-sessions, such as grand-rounds, highlights, debates, clinical cases and other sessions. Read More

View Article and Full-Text PDF

Population-Based Screening for Endometrial Cancer: Human vs. Machine Intelligence.

Front Artif Intell 2020 24;3:539879. Epub 2020 Nov 24.

Department of Therapeutic Radiology, Yale University, New Haven, CT, U.S.A.

Incidence and mortality rates of endometrial cancer are increasing, leading to increased interest in endometrial cancer risk prediction and stratification to help in screening and prevention. Previous risk models have had moderate success with the area under the curve (AUC) ranging from 0.68 to 0. Read More

View Article and Full-Text PDF
November 2020

Same-day discharge after minimal invasive hysterectomy: Applications for improved value of care.

Eur J Obstet Gynecol Reprod Biol 2021 Apr 24;259:140-145. Epub 2021 Feb 24.

Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Women's Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, United States; Magee-Womens Research Institute, Pittsburgh, PA 15213, United States; UPMC Hillman Cancer Center, Pittsburgh, PA 15232, United States; Department of Health Administration and Public Health, John G. Rangos Sr. School of Health Sciences, Duquesne University, Pittsburgh, PA 15219, United States.

Objective: Hysterectomy is one of the most common surgical procedures. Same-day discharge (SDD) is increasingly utilized for minimally invasive hysterectomies, but its uptake varies across healthcare systems and surgical specialties. An evidence-based initiative was developed to aid in the incorporation of SDD into the practice of minimally invasive hysterectomy (MIH) in the UPMC Health System. Read More

View Article and Full-Text PDF

The role of the genetic testing industry in patient education of hereditary cancer: An observational study assessing the quality of patient education videos.

Gynecol Oncol 2021 May 19;161(2):516-520. Epub 2021 Feb 19.

UCLA David Geffen School of Medicine, Los Angeles, CA, USA; UCLA Department of Obstetrics and Gynecology, Los Angeles, CA, USA; Olive View-UCLA Medical Center, Sylmar, CA, USA. Electronic address:

Objectives: Genetic testing (GT) companies have developed patient education videos to supplement or replace pre-test genetic counseling (GC) by certified genetic counselors (CGC). The aim of this study was to assess the quality of these videos compared to the standard of care (SOC).

Methods: Videos from four major GT companies were selected from an internet search identifying pre-test patient education videos. Read More

View Article and Full-Text PDF

Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in Italy.

ESMO Open 2021 04 14;6(2):100053. Epub 2021 Jan 14.

Thoracic Oncology Unit, Medical Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.

Background: Coronavirus disease 2019 (COVID-19) has rapidly spread to every country around the world taking on pandemic proportions. Since 8 March 2020, the Italian government ordered a nationwide lockdown with unavoidable social isolation. Healthcare professionals (HCPs) represent the most physically and emotionally involved category. Read More

View Article and Full-Text PDF